首页> 外文会议>American Peptide Symposium >Studies on a Mutual Prodrug of Sulfamethoxazole and Nalidixic acid
【24h】

Studies on a Mutual Prodrug of Sulfamethoxazole and Nalidixic acid

机译:磺胺甲氧唑和脱硫酸相互前水的研究

获取原文

摘要

The potential of microorganisms is tremendous with respect to their detrimental and perhaps outweighs the beneficial effects with respect to health of a human being. The search for new antibacterial agents is one of the most challenging tasks of the current medicinal chemistry. Nalidixic acid is highly effective against infections with Gram- bacteria, but it is ineffective against most Gram+ bacteria whereas sulfamethoxazole is a broad spectrum antibacterial agent having good action against infections caused by Gram+ bacteria as well. In view of these facts it was considered worthwhile to synthesize a mutual prodrug of sulfamethoxazole and nalidixic acid. The aim of this study has been to synthesize a useful drug, which may act with effectiveness both on the Gram+ and Gram- bacteria.
机译:微生物的潜力对于他们的损害而言是巨大的,也许超过了对人类健康的有益效果。 寻找新的抗菌剂是目前药用化学的最具挑战性的任务之一。 Nalidxic acid对革兰氏细菌感染非常有效,但对大多数革兰氏+细菌来说是无效的,而磺胺甲恶唑是一种宽的抗菌剂,其具有良好的抗菌性抗菌性感染造成的感染。 鉴于这些事实,它被认为是合成相互前药的磺胺甲恶唑和萘啶酸的值得。 本研究的目的一直是合成有用的药物,这可能在克+和革兰氏菌上起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号